Axos Financial, Inc.
NYSE:AXBanks - Regional
+$0.22 today
- Market cap
- $5.00B
- Beta
- 1.25
- P/E (TTM)
- 10.5
- EPS (TTM)
- $8.41
Volume 0.23M
Average 0.40M
AX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Axos Financial, Inc.NYSE: AX
Cash & Equivalents · Q4 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 42.7% from a year ago
Cash & equivalents stood at $1.11B at the end of Q4 FY2026, down 42.7% from a year earlier and down 5.1% from the prior quarter. Over 3 fiscal years it compounded at -20.8% a year.
Context
- Cash & equivalents amounted to 3.7% of total assets at the end of Q4 FY2026, down 4.1 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -42.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2026
- 1.11B USD
- Year-over-year change
- -42.7%
- 4-year CAGR
- -2.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 1.11B | -42.7% |
| FY2025 | 2025-06-30 | 1.93B | -2.3% |
| FY2024 | 2024-06-30 | 1.98B | -11.3% |
| FY2023 | 2023-06-30 | 2.23B | +85.7% |
| FY2022 | 2022-06-30 | 1.2B | — |
Cash & Equivalents vs competitors
How AX compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -42.7% is the 8th highest of 11, against a peer median of -25.7%.
- Cash & equivalents amounts to 3.7% of total assets for AX, versus a peer median of 2.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | COP 19.76T COP | +9.3% | +6.7% | 5.7% | |
| Sep 2026 | $451.3B USD | +57040.5% | -9.7% | 1.2% | |
| Jun 2026 | PEN 15.97B PEN | +30.6% | -2.7% | 15.2% | |
| Jun 2026 | $2.72B USD | -9.1% | +42.9% | 3.2% | |
| Sep 2026 | $1.88B USD | -25.3% | +29.3% | 5.5% | |
| Sep 2026 | $1.15B USD | -63.1% | — | 2.7% | |
| Jun 2026 | $1.11B USD | -42.7% | -20.8% | 3.7% | |
| Sep 2026 | $632.87M USD | -55.6% | -14.1% | 1.6% | |
| Sep 2026 | $471.6M USD | -26.2% | +48.3% | 3.1% | |
| Jun 2026 | $451.16M USD | -38.4% | -36.4% | 2.7% | |
| Sep 2026 | $211.1M USD | -79.8% | -39.0% | 0.7% | |
| Peer median (excluding AX) | — | -25.7% | -2.7% | 2.9% | |
Competitors are the stored peer set for AX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.2B | 2.23B | 1.98B | 1.93B | 1.11B |
| Short-term Investments | 262.52M | 233.11M | 141.16M | 66.06M | 53.73M |
| Net Receivables | 417.42M | 443.65M | 287.46M | 374.27M | 478.26M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 199.17M |
| Total Current Assets | 1.88B | 2.91B | 2.41B | 2.37B | 1.84B |
| Property, Plant & Equipment (Net) | 105.41M | 0 | 0 | 0 | 0 |
| Goodwill | 95.67M | 97.67M | 97.67M | 97.67M | 144.33M |
| Intangible Assets | 85.94M | 79.92M | 73.02M | 64.05M | 130.64M |
| Long-term Investments | 14.11B | 16.48B | 19.25B | 21.06B | 25.62B |
| Tax Assets | 100.78M | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.02B | 781.15M | 1.03B | 1.19B | 2.23B |
| Total Non-current Assets | 15.52B | 17.44B | 20.45B | 22.41B | 28.12B |
| Total Assets | 17.46B | 20.35B | 22.86B | 24.78B | 29.96B |
| Account Payables | 511.65M | 445.48M | 301.13M | 350.61M | 365.79M |
| Short-term Debt | 27.5M | 0 | 30M | 0 | 94M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.95B | 17.12B | 19.36B | 20.83B | 24.57B |
| Total Current Liabilities | 14.49B | 17.57B | 19.69B | 21.18B | 25.03B |
| Long-term Debt | 535.24M | 451.78M | 385.68M | 372.67M | 979.6M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 737.37M | 410.95M | 488.72M | 549.58M | 790.67M |
| Total Non-current Liabilities | 1.27B | 862.73M | 874.39M | 922.25M | 1.77B |
| Total Liabilities | 15.81B | 18.43B | 20.56B | 22.1B | 26.8B |
| Common Stock | 689K | 695K | 702K | 711K | 719K |
| Retained Earnings | 1.43B | 1.74B | 2.19B | 2.62B | 3.11B |
| Accumulated OCI | (2.93M) | (6.61M) | (2.47M) | 348K | 3.91M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.64B | 1.92B | 2.29B | 2.68B | 3.17B |
| Total Debt | 562.74M | 451.78M | 415.68M | 372.67M | 1.07B |
| Net Debt | (639.84M) | (1.78B) | (1.56B) | (1.56B) | (35.04M) |
Axos Financial, Inc.
NYSE:AX
Intrinsic Alpha fair value
Locked
Current Price
$88.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.